These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15062908)
21. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698 [TBL] [Abstract][Full Text] [Related]
22. Effects of breast cancer risk counseling for sexual minority women. Bowen DJ; Powers D; Greenlee H Health Care Women Int; 2006 Jan; 27(1):59-74. PubMed ID: 16338740 [TBL] [Abstract][Full Text] [Related]
23. Exploring family relationships in cancer risk counseling using the genogram. Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645 [TBL] [Abstract][Full Text] [Related]
24. Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire. Erblich J; Brown K; Kim Y; Valdimarsdottir HB; Livingston BE; Bovbjerg DH Patient Educ Couns; 2005 Feb; 56(2):182-91. PubMed ID: 15653247 [TBL] [Abstract][Full Text] [Related]
25. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048 [TBL] [Abstract][Full Text] [Related]
26. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer]. Loman N Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304 [TBL] [Abstract][Full Text] [Related]
27. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860 [TBL] [Abstract][Full Text] [Related]
28. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736 [TBL] [Abstract][Full Text] [Related]
30. Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Dawson SJ; Price MA; Jenkins MA; McKinley JM; Butow PN; McLachlan SA; Lindeman GJ; Weideman P; Friedlander ML; Hopper JL; Phillips KA J Clin Oncol; 2008 Jan; 26(2):225-32. PubMed ID: 18040054 [TBL] [Abstract][Full Text] [Related]
31. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Lester J Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169 [TBL] [Abstract][Full Text] [Related]
32. Women's awareness of ovarian cancer risks and symptoms. Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232 [TBL] [Abstract][Full Text] [Related]
33. Women's decisions regarding management of breast cancer risk. MacDonald DJ Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430 [TBL] [Abstract][Full Text] [Related]
34. Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility? Schwartz MD; Tercyak KP; Peshkin BN; Valdimarsdottir H Nat Clin Pract Oncol; 2005 Jan; 2(1):24-5. PubMed ID: 16264852 [No Abstract] [Full Text] [Related]
35. [In cases of familial ovarian cancer, always consider the risk of breast cancer]. Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897 [TBL] [Abstract][Full Text] [Related]
36. Communicating breast cancer risks to women using different formats. Lipkus IM; Klein WM; Rimer BK Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):895-8. PubMed ID: 11489757 [TBL] [Abstract][Full Text] [Related]
37. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Forman AD; Hall MJ Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331 [TBL] [Abstract][Full Text] [Related]
38. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K; Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319 [TBL] [Abstract][Full Text] [Related]
39. Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness. Meischke H; Bowen D; Kuniyuki A Cancer Detect Prev; 2001; 25(4):319-27. PubMed ID: 11531008 [TBL] [Abstract][Full Text] [Related]
40. Predictors of participation in genetic research in a primary care physician network. Helmes AW; Bowen DJ; Bowden R; Bengel J Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1377-9. PubMed ID: 11142425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]